Log in
0 followers
TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.
Industries
Headquarters
Stage
Employees
Links
4 members
0 members
1 members
Heliex.AI
7 followers
VideaHealth
3 followers
New York University
123 followers
UnitedHealth Group
253 followers
Mission Bio
4 followers
Discover companies